BioForce Nanosciences HLD closed fiscal year 2025 with $786 in total assets, $619K in total liabilities and -$619K in shareholder equity. Total assets fell 8.8% from the prior fiscal year. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters BioForce Nanosciences HLD has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
BFNH Balance Sheet by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $786-8.8% | $862+35.1% | $638-13.1% | $734-93.4% | $11K-72.0% | $40K-32.3% | $59K+67.7% | $35K+68.0% | $21K |
| Total Liabilities | $619K-73.1% | $2.3M+26.5% | $1.8M+35.0% | $1.3M+54.4% | $873K+118.4% | $400K+3350.2% | $12K+117.7% | $5K-58.1% | $13K |
| Total Equity | -$619Kn/m | -$2.3Mn/m | -$1.8Mn/m | -$1.3Mn/m | -$862Kn/m | -$360K-860.8% | $47K+58.7% | $30K+263.4% | $8K |
BFNH Balance Sheet by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.2M+285443.5% | $2.4M+263775.7% | $6K-54.0% | $786-8.8% | $784-52.0% | $905+35.7% | $14K+2056.1% | $862+35.1% | $2K+138.3% | $667+2.0% | $640-6.7% | $638-13.1% |
| Total Liabilities | $277K-44.7% | $85K-78.0% | $727K+164.4% | $619K-73.1% | $501K-77.0% | $385K-81.4% | $275K-85.9% | $2.3M+26.5% | $2.2M+27.8% | $2.1M+29.7% | $2.0M+32.0% | $1.8M+35.0% |
| Total Equity | $2.0Mn/m | $2.3Mn/m | -$721Kn/m | -$619Kn/m | -$500Kn/m | -$384Kn/m | -$261Kn/m | -$2.3Mn/m | -$2.2Mn/m | -$2.1Mn/m | -$2.0Mn/m | -$1.8Mn/m |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More BioForce Nanosciences HLD financials
Frequently Asked Questions
BioForce Nanosciences HLD closed fiscal year 2025 with $786 in total assets, $619K in total liabilities and -$619K in shareholder equity.
BioForce Nanosciences HLD (BFNH) total assets fell by 8.8% year over year, from $862 to $786 in fiscal year 2025.
Across the 9 fiscal years this page covers, BioForce Nanosciences HLD (BFNH) total assets went from $21K in fiscal year 2017 to $786 in fiscal year 2025.
BioForce Nanosciences HLD (BFNH) reported $2.2M in total assets in Q3 2026. This represents an increase of 285443.5% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what BioForce Nanosciences HLD (BFNH) reported on that line in every period on record.